| Stage | HAS | % of rev | JAKK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $254M | 100.00% | HAS ×6.28 |
| Gross profit | $1.2B | 75.88% | $82M | 32.06% | HAS +43.8pp |
| Operating income | $517M | 32.43% | $37M | 14.70% | HAS +17.7pp |
| Pre-tax income | $489M | 30.66% | $38M | 14.80% | HAS +15.9pp |
| Net income | $395M | 24.76% | $30M | 11.76% | HAS +13.0pp |
| Stage | HAS | JAKK | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $254M100.00% | HAS ×6.28 |
| Gross profit | 75.88%$1.2B | 32.06%$82M | HAS +43.8pp |
| Operating income | 32.43%$517M | 14.70%$37M | HAS +17.7pp |
| Pre-tax income | 30.66%$489M | 14.80%$38M | HAS +15.9pp |
| Net income |
| 24.76%$395M |
| 11.76%$30M |
| HAS +13.0pp |
No disclosed counterparties: JAKK.
None